NEOG Neogen Corp

Price (delayed)

$24.05

Market cap

$2.59B

P/E Ratio

52.28

Dividend/share

N/A

EPS

$0.46

Enterprise value

$2.55B

NEOGEN Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural ...

Highlights
NEOG's price to earnings (P/E) is 32% less than its last 4 quarters average of 76.8 and 17% less than its 5-year quarterly average of 63.1
The revenue has grown by 14% YoY and by 2.3% from the previous quarter
The quick ratio is down by 25% year-on-year and by 7% since the previous quarter
The EPS is down by 22% year-on-year and by 15% since the previous quarter

Key stats

What are the main financial stats of NEOG
Market
Shares outstanding
107.82M
Market cap
$2.59B
Enterprise value
$2.55B
Valuations
Price to earnings (P/E)
52.28
Price to book (P/B)
2.96
Price to sales (P/S)
5.04
EV/EBIT
41.5
EV/EBITDA
29.93
EV/Sales
4.96
Earnings
Revenue
$514.49M
EBIT
$61.44M
EBITDA
$85.21M
Free cash flow
$50.41M
Per share
EPS
$0.46
Free cash flow per share
$0.47
Book value per share
$8.12
Revenue per share
$4.77
TBVPS
$6.67
Balance sheet
Total assets
$981.21M
Total liabilities
$105.66M
Debt
$0
Equity
$875.54M
Working capital
$543.92M
Liquidity
Debt to equity
0
Current ratio
9.28
Quick ratio
7.17
Net debt/EBITDA
-0.5
Margins
EBITDA margin
16.6%
Gross margin
45.8%
Net margin
9.5%
Operating margin
11.8%
Efficiency
Return on assets
5.2%
Return on equity
5.7%
Return on invested capital
10.4%
Return on capital employed
6.7%
Return on sales
11.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NEOG stock price

How has the Neogen stock price performed over time
Intraday
0.04%
1 week
3.22%
1 month
-9.86%
1 year
-48.28%
YTD
-47.04%
QTD
-22.02%

Financial performance

How have Neogen's revenue and profit performed over time
Revenue
$514.49M
Gross profit
$235.71M
Operating income
$60.85M
Net income
$49.11M
Gross margin
45.8%
Net margin
9.5%
The net margin is down by 31% year-on-year and by 16% since the previous quarter
The operating margin is down by 28% year-on-year and by 16% since the previous quarter
Neogen's net income has decreased by 20% YoY and by 14% from the previous quarter
The company's operating income fell by 18% YoY and by 13% QoQ

Growth

What is Neogen's growth rate over time

Valuation

What is Neogen stock price valuation
P/E
52.28
P/B
2.96
P/S
5.04
EV/EBIT
41.5
EV/EBITDA
29.93
EV/Sales
4.96
NEOG's price to earnings (P/E) is 32% less than its last 4 quarters average of 76.8 and 17% less than its 5-year quarterly average of 63.1
The EPS is down by 22% year-on-year and by 15% since the previous quarter
The P/B is 46% less than the 5-year quarterly average of 5.5 and 43% less than the last 4 quarters average of 5.2
Neogen's equity has increased by 8% YoY
The price to sales (P/S) is 45% lower than the last 4 quarters average of 9.1 and 43% lower than the 5-year quarterly average of 8.8
The revenue has grown by 14% YoY and by 2.3% from the previous quarter

Efficiency

How efficient is Neogen business performance
The ROS is down by 30% year-on-year and by 16% since the previous quarter
The ROA is down by 30% year-on-year and by 16% since the previous quarter
Neogen's return on equity has decreased by 29% YoY and by 16% QoQ
The return on invested capital has declined by 29% year-on-year and by 15% since the previous quarter

Dividends

What is NEOG's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NEOG.

Financial health

How did Neogen financials performed over time
The total liabilities is up by 46% year-on-year and by 4.4% since the previous quarter
The quick ratio is down by 25% year-on-year and by 7% since the previous quarter
The debt is 100% smaller than the equity
Neogen's equity has increased by 8% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.